VYNE Therapeutics’ mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond.
Location: United States, California, Menlo Park
Employees: 51-200
Total raised: $100M
Founded date: 2003
Investors 5
Date | Name | Website |
- | Aisling Ca... | aislingcap... |
- | F-Prime Ca... | fprimecapi... |
14.09.2021 | Vivo Capit... | vivocapita... |
- | Eight Road... | eightroads... |
- | Bay City C... | baycitycap... |
Funding Rounds 2
Date | Series | Amount | Investors |
01.02.2021 | - | $50M | - |
18.07.2017 | Series C | $50M | F-Prime Ca... |
Mentions in press and media 14
Date | Title | Description | Source |
01.11.2023 | VYNE Therapeutics Announces Closing of Previously Announced ... | - | globenewsw... |
30.10.2023 | VYNE Therapeutics Announces Private Placement of $88 Million | - | globenewsw... |
01.02.2021 | VYNE THERAPEUTICS INC. VYNE Therapeutics : Announces Closin... | BRIDGEWATER - VYNE Therapeutics Inc. (Nasdaq: VYNE) ('VYNE' or the 'Company') today announced that i... | marketscre... |
01.02.2021 | VYNE Therapeutics : Announces Closing of $50 Million Registe... | BRIDGEWATER - VYNE Therapeutics Inc. (Nasdaq: VYNE) ('VYNE' or the 'Company') today announced that i... | marketscre... |
29.01.2021 | VYNE THERAPEUTICS INC. VYNE Therapeutics : Announces Closin... | BRIDGEWATER, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” o... | marketscre... |
29.01.2021 | VYNE Therapeutics : Announces Closing of $50 Million Registe... | BRIDGEWATER, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” o... | marketscre... |
24.01.2018 | Term Sheet — Wednesday, January 24 | 5 Qs WITH A DEALMAKER Four years ago, Arlan Hamilton was living out of a hotel room that she shared... | fortune.co... |
12.01.2018 | Term Sheet — Friday, January 12 | CUDDLE PUDDLES Good morning, Term Sheet readers. Paid Content Securing the enterprise without boun... | fortune.co... |
18.07.2017 | Rock Springs Capital Joins $50M Series C for Menlo Therapeut... | Menlo Therapeutics Inc. announced today that the company has raised $50M to advance development of s... | citybizlis... |
18.07.2017 | Term Sheet — Tuesday, July 18 | WHERE THE BEER FLOWS LIKE WINE Hello from Aspen again. Yesterday kicked off day one of Fortune’s Br... | fortune.co... |
Show more